Skip to content
Medical Health Aged Care

CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024

CGFNS International 3 mins read

Uncertain outlook for 2025 as new immigration policies are implemented

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 11, 2025 / A new CGFNS International report indicates that a robust annual rate of nurse migration into the United States held steady in 2024 as healthcare systems continued to look to foreign-educated nurses to help address persistent staffing shortages.CGFNS International 2024 Nurse Migration Report

CGFNS International 2024 Nurse Migration Report

However, in its 2024 Nurse Migration Report, the organization also said the current high rates were likely unsustainable amid persisting visa retrogression and caps on employment-based green cards for nurses, along with new immigration policies being implemented by the Trump Administration that will likely have further impact on visa availability and processing times.

CGFNS, a global health workforce non-profit that verifies credentials of healthcare professionals for immigration authorities and state licensing boards, reported that in fiscal year 2024 it received 24,733 applications for its VisaScreen® (VS) service. While this is a 4.6% drop from FY 2023, the organization noted application levels remain significantly higher than pre-pandemic figures, with the 2024 figure at nearly 200% above FY 2018.

Other key data from the report:

  • While VS certifications went to nurses from more than 100 countries in 2024, 92% were educated in one of the top 10 countries on the list.

  • The Philippines continued to account for more than 51% of VS certificates, followed by Canada with 8% and Kenya with 6.5%. There has been a slight shift in this distribution recently, with the Philippines dropping from 60% of the total last year, while Kenya, Nigeria, and Ghana have all showed considerable growth in their share.

  • Like countries of education, visa categories are also significantly concentrated, with 76% of VS certificates issued to those seeking permanent green cards (such as EB-3 visas), while TN (12%) and H1-B (11%) made up the only other significant categories.

"These figures confirm what others are seeing, that U.S. healthcare systems continue to depend on nurse immigrants to address persistent staffing shortages. Disruptions to this pipeline of qualified nurses would have far-reaching consequences, exacerbating workforce shortages, increasing patient care loads, and worsening nurse burnout," said Dr. Peter Preziosi, President and CEO of CGFNS. "This is a multilayered global challenge that demands collaborative and innovative solutions among source and receiving countries."

CGFNS International is approved by the U.S. Department of Homeland Security to satisfy federal credential screening requirements for occupational visas for nine categories of foreign-educated healthcare professionals.

To offer global context for the U.S. numbers, the report also analyzes worldwide migration of nurses and healthcare professionals, particularly as both source and destination countries continue to grapple with balancing the demand for skilled healthcare workers against the challenges of retaining their domestic workforces. It noted that some countries in Africa, including Zimbabwe and Ghana, have paused the release of certificates that are needed by nurses to emigrate, while Nigeria has introduced in-country service requirements that nurses must fulfill prior to migration. Other governments, such as Namibia, have pursued the pathway of creating incentives for nurses who choose to stay.

Download the 2024 Nurse Migration Report: Balancing sustained workforce demand amid shifting migration flows.

Contact Information

David St. John
[email protected]

.

SOURCE: CGFNS International



View the original press release on ACCESS Newswire

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.